2D-Cosy NMR Spectroscopy as a Quantitative Tool in Biological Matrix: Application to Cyclodextrins

AAPS Journal

Volumn 17, Issue 6, 2015, Pages 1501-1510

  Dufour, Gilles ^a   Evrard, Brigitte ^a   de Tullio, Pascal ^b  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

2D NMR; biological matrices; cyclodextrins; poloxamers; quantification

Indexed keywords

2 HYDROXYPROPYL BETA CYCLODEXTRIN; POLOXAMER; CYCLODEXTRIN;

2D CORRELATION SPECTROSCOPY; ACCURACY; ANALYTICAL ERROR; ARTICLE; CALIBRATION; CELL NUCLEUS MATRIX; INFANT; LIMIT OF QUANTITATION; LINEAR SYSTEM; MALE; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; QUANTITATIVE ANALYSIS; RANDOM ERROR; VALIDATION PROCESS; BLOOD; HUMAN; PROCEDURES; STANDARDS;

CYCLODEXTRINS; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY;

EID: 84945490815     PISSN: None     EISSN: 15507416     Source Type: Journal    
DOI: 10.1208/s12248-015-9806-9     Document Type: Article

References (34)

1. Bharti SK, Roy R. Quantitative 1H NMR spectroscopy. TrAC Trends Anal Chem. 2012;35:5–26.
2. Holzgrabe U. Quantitative NMR, spectroscopy in pharmaceutical applications. Prog Nucl Magn Reson Spectrosc. 2010;57(2):229–40.
3. Simmler C, Napolitano JG, McAlpine JB, Chen SN, Pauli GF. Universal quantitative NMR analysis of complex natural samples. Curr Opin Biotechnol. 2014;25:51–9.
4. Hachem R, Malet-Martino M, Gilard V. First identification and quantification of lorcaserin in an herbal slimming dietary supplement. J Pharm Biomed Anal. 2014;98:94–9.
5. Holzgrabe U, Malet-Martino M. NMR spectroscopy in pharmaceutical and biomedical analysis. J Pharm Biomed Anal. 2014;93:1–2.
6. Pauli GF, Godecke T, Jaki BU, Lankin DC. Quantitative 1H NMR. Development and potential of an analytical method: an update. J Nat Prod. 2012;75(4):834–51.
7. Holzgrabe U, Deubner R, Schollmayer C, Waibel B. Quantitative NMR spectroscopy—applications in drug analysis. J Pharm Biomed Anal. 2005;38(5):806–12.
8. Lewis IAS, Schommer SC, Hodis B, Robb KA, Tonelli M, Westler WM, et al. Method for determining molar concentrations of metabolites in complex solutions from two-dimensional 1H- 13C NMR spectra. Anal Chem. 2007;79:6.
9. Giraudeau P. Quantitative 2D liquid-state NMR. Magn Reson Chem. 2014;52(6):259–72.
10. Bingol K, Zhang F, Bruschweiler-Li L, Bruschweiler R. Quantitative analysis of metabolic mixtures by two-dimensional 13C constant-time TOCSY NMR spectroscopy. Anal Chem. 2013;85(13):6414–20.
11. Gronwald MSK, Kaspar H, Fagerer SR, Nurnberger N, Dettmer K, Bertsch T, et al. Urinary metabolite quantification employing 2D NMR spectroscopy. Anal Chem. 2008;80:10.
12. Hu F, Furihata K, Kato Y, Tanokura MJ. Nondestructive quantification of organic compounds in whole milk without pretreatment by two-dimensional NMR spectroscopy. J Agric Food Chem. 2007;55:5.
13. Jiang H, Sidhu R, Fujiwara H, De Meulder M, de Vries R, Gong Y, et al. Development and validation of sensitive LC-MS/MS assays for quantification of 2-hydroxypropyl-β-cyclodextrin in human plasma and CSF. J Lipid Res. 2014;55(7):12.
14. Szeman J, Gerloczy A, Csabai K, Szejtli J, Kis GL, Su P, et al. High-performance liquid chromatographic determination of 2-hydroxypropyl-g-cyclodextrin in different biological fluids based on cyclodextrin enhanced fluorescence. J Chromatogr B. 2002;774:8.
15. Soga M, Ishitsuka Y, Hamasaki M, Yoneda K, Furuya H, Matsuo M, et al. HPGCD Outperforms HPBCD as A Potential Treatment for Niemann-Pick Disease Type C During disease Modeling with iPS Cells. Stem cells. 2014.
16. Liu B, Turley SD, Burns DK, Miller AM, Repa JJ, Dietschy JM. Reversal of defective lysosomal transport in NPC disease ameliorates liver dysfunction and neurodegeneration in the npc1-/- mouse. Proc Natl Acad Sci U S A. 2009;106(7):2377–82.
17. Brewster ME, Loftsson T. Cyclodextrins as pharmaceutical solubilizers. Adv Drug Deliv Rev. 2007;59(7):645–66.
18. Loftsson T, Brewster ME. Pharmaceutical applications of cyclodextrins: basic science and product development. J Pharm Pharmacol. 2010;62(11):1607–21.
19. Del Valle EMM. Cyclodextrins and their uses: a review. Process Biochem. 2004;39(9):1033–46.
20. Camargo F, Erickson RP, Garver WS, Hossain GS, Carbone PN, Heidenreich RA, et al. Cyclodextrins in the treatment of a mouse model of Niemann-Pick C disease. Life Sci. 2001;70(2):131–42.
21. Batrakova EV, Kabanov AV. Pluronic block copolymers: evolution of drug delivery concept from inert nanocarriers to biological response modifiers. J Control Release: Off J Control Release Soc. 2008;130(2):98–106.
22. Kabanov AV, Batrakova EV, Sriadibhatla S, Yang Z, Kelly DL, Alakov VY. Polymer genomics: shifting the gene and drug delivery paradigms. J Control Release: Off J Control Release Soc. 2005;101(1-3):259–71.
23. Chylla RA, Hu K, Ellinger JJ, Markley JL. Deconvolution of two-dimensional NMR spectra by fast maximum likelihood reconstruction: application to quantitative metabolomics. Anal Chem. 2011;83(12):4871–80.
24. Boulanger B, Rozet E, Moonen F, Rudaz S, Hubert P. A risk-based analysis of the AAPS conference report on quantitative bioanalytical methods validation and implementation. J Chromatogr B Anal Technol Biomed Life Sci. 2009;877(23):2235–43.
25. Hubert P, Nguyen-Huu JJ, Boulanger B, Chapuzet E, Chiap P, Cohen N, et al. Harmonization of strategies for the validation of quantitative analytical procedures. A SFSTP proposal—part I. J Pharm Biomed Anal. 2004;36(3):579–86.
26. Rozet E, Marini RD, Ziemons E, Boulanger B, Hubert P. Advances in validation, risk and uncertainty assessment of bioanalytical methods. J Pharm Biomed Anal. 2011;55(4):848–58.
27. Dufour G, Evrard B, de Tullio P. Rapid quantification of 2-hydroxypropyl-beta-cyclodextrin in liquid pharmaceutical formulations by 1H nuclear magnetic resonance spectroscopy. Eur J Pharm Sci: Off J Eur Fed Pharm Sci. 2015;73:20–8.
28. International Conference on Harmonization (ICH) of Technical Requirements for Registration of Pharmaceuticals for Human Use TQRVoAPTaM, Geneva. International Conference on Harmonization (ICH) of Technical Requirements for Registration of Pharmaceuticals for Human Use, Topic Q2 (R1): Validation of Analytical Procedures: Text and Methodology, Geneva. 2005.
29. Rozet E, Ceccato A, Hubert C, Ziemons E, Oprean R, Rudaz S, et al. Using tolerance intervals in pre-study validation of analytical methods to predict in-study results. J Chromatogr A. 2007;1158:111–25.
30. Mao Y, Thompson MJ, Wang Q, Tsai EW. Quantitation of poloxamers in pharmaceutical formulations using size exclusion chromatography and colorimetric methods. J Pharm Biomed Anal. 2004;35(5):1127–42.
31. Nair LM, Konkel J, Thomas M, Koberda M. Comparison of electrospray ionization mass spectrometry and evaporative light scattering detections for the determination of Poloxamer 188 in itraconazole injectable formulation. J Pharm Biomed Anal. 2006;41(3):725–30.
32. Urban-Morlan Z, Castro-Rios R, Chavez-Montes A, Melgoza-Contreras LM, Pinon-Segundo E, Ganem-Quintanar A, et al. Determination of poloxamer 188 and poloxamer 407 using high-performance thin-layer chromatography in pharmaceutical formulations. J Pharm Biomed Anal. 2008;46(4):799–803.
33. Gould S, Scott RC. 2-Hydroxypropyl-beta-cyclodextrin (HP-beta-CD): a toxicology review. Food Chem Toxicol: Int J Publ Br Ind Biol Res Assoc. 2005;43(10):1451–9.
34. Giraudeau P, Frydman L. Ultrafast 2D NMR: an emerging tool in analytical spectroscopy. Annu Rev Anal Chem. 2014;7:129–61.